Robert Thomas Freeman is CFO at Alignment Healthcare, Inc. (ALHC). They have made 24 open-market trades across 1 company since 2021, most recently 2025-03-27.
CIK 0001850414
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALHC | 1,464,419 | $12.2M |
Shares reported on the most recent Form 4, priced at the 2025-03-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALHC | SELL | 2025-03-27 | 2025-03-28 | $17.89 | $241K | +2.7% | -2.0% | -23.8% |
| ALHC | SELL | 2025-03-18 | 2025-03-19 | $16.67 | $842K | +11.2% | +4.5% | -13.0% |
| ALHC | SELL | 2025-03-12 | 2025-03-13 | $15.42 | $450K | +13.9% | +23.8% | -0.1% |
| ALHC | SELL · 10b5-1 | 2025-03-04 | 2025-03-06 | $15.55 | $10.7M | +9.0% | +16.0% | -0.3% |
| ALHC | SELL · 10b5-1 | 2024-11-11 | 2024-11-13 | $13.42 | $409K | -2.0% | -9.4% | +13.8% |
| ALHC | SELL · 10b5-1 | 2024-10-29 | 2024-10-31 | $12.04 | $979K | +6.0% | +3.4% | +23.3% |
| ALHC | SELL · 10b5-1 | 2024-10-14 | 2024-10-16 | $11.50 | $351K | -1.9% | -2.3% | +14.9% |
| ALHC | SELL · 10b5-1 | 2024-10-08 | 2024-10-10 | $12.04 | $947K | -3.3% | +20.9% | +7.5% |
| ALHC | SELL | 2024-10-01 | 2024-10-03 | $10.92 | $533K | -0.1% | +22.3% | +6.3% |
| ALHC | SELL · 10b5-1 | 2024-09-11 | 2024-09-13 | $10.98 | $1.7M | -5.9% | -4.8% | -7.0% |
| ALHC | SELL | 2024-09-04 | 2024-09-06 | $10.00 | $64K | +21.5% | +15.8% | +30.2% |
| ALHC | SELL | 2024-07-17 | 2024-07-19 | $10.01 | $1.4M | -10.9% | -12.4% | +16.5% |
| ALHC | SELL | 2024-03-28 | 2024-03-29 | $4.84 | $21K | -4.0% | +2.4% | +58.3% |
| ALHC | SELL | 2024-03-19 | 2024-03-21 | $5.05 | $288K | -7.8% | +3.3% | +46.2% |
| ALHC | SELL | 2024-03-15 | 2024-03-15 | $4.89 | $116K | -1.2% | -2.9% | +67.6% |
| ALHC | SELL | 2023-03-29 | 2023-03-31 | $6.17 | $53K | +6.0% | +6.0% | -7.9% |
| ALHC | SELL | 2023-03-14 | 2023-03-15 | $6.33 | $171K | +5.2% | +10.0% | +25.3% |
| ALHC | SELL · 10b5-1 | 2023-01-18 | 2023-01-20 | $13.01 | $14K | +1.2% | -13.2% | -58.5% |
| ALHC | SELL | 2022-12-01 | 2022-12-02 | $13.10 | $314K | -8.4% | -10.8% | -43.2% |
| ALHC | SELL | 2022-11-01 | 2022-11-02 | $13.23 | $318K | +0.2% | -1.1% | -5.3% |
| ALHC | SELL | 2022-10-26 | 2022-10-28 | $13.08 | $314K | -4.0% | -3.9% | -8.5% |
| ALHC | SELL | 2022-09-01 | 2022-09-02 | $14.56 | $349K | +7.0% | -18.4% | -13.0% |
| ALHC | SELL | 2022-08-05 | 2022-08-09 | $18.54 | $1.6M | -13.0% | -3.4% | -27.6% |
| ALHC | SELL | 2022-08-01 | 2022-08-02 | $14.50 | $348K | +6.9% | -4.0% | -14.1% |
| ALHC | SELL | 2022-07-05 | 2022-07-07 | $12.48 | $509K | +1.9% | +18.5% | -13.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.